Raia Drogasil SA
BOVESPA:RADL3
Intrinsic Value
Raia Drogasil SA engages in the retail sale of medicine, perfumery, personal care and beauty products, cosmetics and dermocosmetics. [ Read More ]
The intrinsic value of one RADL3 stock under the Base Case scenario is 22.52 BRL. Compared to the current market price of 25.58 BRL, Raia Drogasil SA is Overvalued by 12%.
Valuation Backtest
Raia Drogasil SA
Run backtest to discover the historical profit from buying and selling RADL3 stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Raia Drogasil SA
Current Assets | 11.6B |
Cash & Short-Term Investments | 412.3m |
Receivables | 3.8B |
Other Current Assets | 7.3B |
Non-Current Assets | 8.5B |
Long-Term Investments | 15m |
PP&E | 5.9B |
Intangibles | 1.9B |
Other Non-Current Assets | 662.8m |
Current Liabilities | 8.1B |
Accounts Payable | 5.1B |
Accrued Liabilities | 877.2m |
Other Current Liabilities | 2.1B |
Non-Current Liabilities | 6.1B |
Long-Term Debt | 5.6B |
Other Non-Current Liabilities | 454.5m |
Earnings Waterfall
Raia Drogasil SA
Revenue
|
34B
BRL
|
Cost of Revenue
|
-23.8B
BRL
|
Gross Profit
|
10.2B
BRL
|
Operating Expenses
|
-8B
BRL
|
Operating Income
|
2.2B
BRL
|
Other Expenses
|
-1.1B
BRL
|
Net Income
|
1.1B
BRL
|
Free Cash Flow Analysis
Raia Drogasil SA
RADL3 Profitability Score
Profitability Due Diligence
Raia Drogasil SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Raia Drogasil SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
RADL3 Solvency Score
Solvency Due Diligence
Raia Drogasil SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Raia Drogasil SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RADL3 Price Targets Summary
Raia Drogasil SA
According to Wall Street analysts, the average 1-year price target for RADL3 is 31.49 BRL with a low forecast of 24.24 BRL and a high forecast of 36.75 BRL.
Shareholder Return
RADL3 Price
Raia Drogasil SA
Average Annual Return | 17.46% |
Standard Deviation of Annual Returns | 33.74% |
Max Drawdown | -17% |
Market Capitalization | 43.9B BRL |
Shares Outstanding | 1 714 382 358 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Raia Drogasil SA engages in the retail sale of medicine, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The company is headquartered in Sao Paulo, Sao Paulo and currently employs 50,573 full-time employees. The company went IPO on 2010-10-20. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in the Distrito Federal. The firm operates through a range of subsidiaries, such as Raia SA and 4-Bio Medicamentos SA.
Contact
IPO
Employees
Officers
The intrinsic value of one RADL3 stock under the Base Case scenario is 22.52 BRL.
Compared to the current market price of 25.58 BRL, Raia Drogasil SA is Overvalued by 12%.